(4)Applications and supplementary dossiers for the renewal of the approvals of each of those active substances were submitted in accordance with Commission Implementing Regulation (EU) 2020/1740note three years before the extended expiry date of the active substances. On 3 May 2023, 11 April 2022, 28 June 2022 and 4 July 2022 the rapporteur Member States of amisulbrom, S-abscisic acid, thiencarbazone and valifenalate respectively informed the Commission that they had checked the admissibility, in particular the completeness and the timeliness, of each of these applications, and concluded that they were admissible.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.